BCAT2 and cancer: Furthermore, immunostaining showed that both BCAT1 and BCAT2 were highly expressed in cancer cells when comparing noncancerous cholangiocytes (FS1 is a representative case; Fig. 4d and Supplementary Fig. S4A, B).